Diet and functional foods in treatment and maintenance therapy of colon disorders

Journal of Applied Pharmaceutical Science

Volumn 2, Issue 4, 2012, Pages 177-187

  Kumar, Dinesh ^a   Singh, Gurmeet ^a   Singh, Mankaran ^a   Sharma, Deepak ^a   Rathore, Mahendra Singh ^a  

^a Shahpur Campus   (India)

Author keywords

Colon diseases; Diet; Prebiotics; Probiotics; Synbiotics

Indexed keywords

EID: 84876040553     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: 10.7324/JAPS.2012.2506     Document Type: Review

References (88)

1. Baron J.A., Sandler R.S., Haile R.W., Mandel J.S., Mott L.A., Greenberg E.R. Folate intake, alcohol consumption, cigarette smoking, and risk of colorectal adenomas. J. Nat. Cancer Inst. 1998; 90: 57-62.
2. Bergsma-Kadijk J.A., van't Veer P., Kampman E., Burema J. Calcium does not protect against colorectal neoplasia. Epidemiol. 1996; 7: 590-597.
3. Bouhnik Y., Vahedi K., Achour L., Attar A., Salfati J., Pochart P., Marteau P., Flourie B., Bornet F. Rambaud J.C. Short-chain fructooligosaccharide administration dose dependently increases fecal bifidobacteria in healthy humans. J. Nutr. 1999; 129: 113-116.
4. Buddington R.K.Williams C.H., Chen S.C., Witherly S.A. Dietary supplement of neosugar alters the faecal flora and decreases the activities of some reductive enzymes in human subjects. Am. J. Clin. Nutr. 1996; 63: 709-716.
5. Cappell M.S. The pathophysiology, clinical presentation, and diagnosis of colon cancer and adenomatous polyps. Med. Clin. North Am. 2005; 89: 1-42.
6. Chakraborti C.K. The status of synbiotics in colorectal cancer. Life Sci. Med. Res. 2011; 2011: 1-20.
7. Challa A., Rao D.R., Chawan C.B., Shackelford L. Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis. 1997; 18(3): 517-521.
8. Chourasia M.K., Jain S.K. Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Pharm. Sci. 2003; 6(1): 33-66.
9. Crittenden R., Playne M.J. (2006). Modifying the human intestinal microbiota with prebiotics. In A.C. Ouwehand, E.E. Vaughan (Ed.) Gastrointestinal Microbiology (pp. 285-314). New York: Taylor & Francis Group.
10. Cummings J.H., Macfarlane G.T., Englyst H.N. Prebiotic digestion and fermentation. Am. J Clin. Nutr. 2001; 73: S415-S420.
11. Den Hond E., Geypens B., Ghoos Y. Effect if high performance chicory inulin on constipation. Nutr. Res. 2000; 20: 731-736.
12. Donovan S., Gibson G., Newburg D. Prebiotics in infant nutrition. Mead Johnson Nutr. 2008: 1-37.
13. Farthing M.L. Bugs and the gut: an unstable marriage. Best Pract. Res. Clin. Gastroenterol.2004;18:233-239.
14. Femia A.P., Luceri C., Dolara P., Giannini A, Biggeri A., Salvadori M., Clune Y., Collins K.J., Paglierani M., Caderni G. Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats. Carcinogenesis. 2002; 23(11): 1953-1960.
15. Fisher R.G., Denison M.R. Veillonella parvula bacteremia without an underlying source. J. Clin. Microbiol. 1996; 34(12): 3235- 3236.
16. Fuchs C.S., Giovannucci E.L., Colditz G.A., Hunter D.J., Stampfer M.J., Rosner B., et al. Dietary fiber and the risk of colorectal cancer and adenoma in women. N. Engl. J. Med. 1999; 340: 169-176.
17. Gallaher D.D., Khil, J. The effect of synbiotics on colon carcinogenesis in rats. J. Nutr. 1999; 129: S1483-S1487.
18. Ghadirian P., Maisonneuve P., Perret C., Kennedy G., Boyle P., Krewski D., et al. A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect. Prev. 2000; 24: 305-313.
19. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 1995; 125: 1401-1412.
20. Gibson G.R., Wang X. Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture. FEMS Microbiol. Lett. 1994; 118: 121-128.
21. Grajek W., Olejnik A., Sip A. Probiotics, prebiotics and antioxidants as functional foods. Acta Biochim. Pol. 2005; 52(3): 665-671.
22. Guarner F., Malagelada J.R. Gut flora in health and disease. Lancet. 2003; 361(9356): 512-519.
23. Haenszel W., Kurihara M. Studies of Japanese immigrants: I. Mortality from cancer and other diseases among Japanese in the United States. J. Nat. Cancer Inst. 1968; 40: 43-68.
24. Harish K., Varghese T. Probiotics in humans - Evidence based review. Calicut Med. J. 2006; 4(4): e3(1-11).
25. Hentges D.J. (1992). Gut flora and disease resistance. In R. Fuller (Ed.) Probiotics: The Scientific Basis (pp. 87-109). London: Chapman and Hall publishers.
26. Hidaka H., Eida T., Takizawa T., Tokunaga T., Tashiro Y. Effects of fructo-oligosaccharides on intestinal flora and human health. Bifidobacteria Microflora. 1986; 5: 37-50.
27. Hill M.H., Draser B.S., Aries V., Crowther J.S., Hawk-sworth G., Williams, R.E.O. Bacteria and etiology of cancer of large bowel. Lancet. 1971; 297(7690): 95-100.
28. Howe G.R., Benito E., Castelleto R., Cornee J., Esteve J., Gallagher R.P., et al. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 casecontrol studies. J. Nat. Cancer Inst. 1992; 84: 1887-1896.
29. Hughes R., Rowland I.R. Stimulation of apoptosis by two prebiotic chicory fructans in the rat colon. Carcinogenesis. 2001; 22(1): 43-47.
30. Isabel M., Correia T.D., Nicoli J.R. The role of probiotics in gastrointestinal surgery. Curr. Opin. Clin. Nutr. Metab. Care. 2006; 9: 618-621.
31. Jonkers D., Stockbrügger R. Probiotics and inflammatory bowel disease. J. R. Soc. Med. 2003; 96: 167-171.
32. Kampman E., Verhoeven D., Sloots L., van't Veer P. Vegetable and animal products as determinants of colon cancer in Dutch men and women. Cancer Causes Control. 1996; 6: 225-234.
33. Karppinen S., Liukkonen K., Aura A.M., Forsell P. Poutanen K. In vitro fermentation of polysacharides of rye, wheat and oat brans and inulin by human faecal bacteria. J. Sci. Food Agric. 2000; 80: 1469-1476.
34. Kefalides P.T., Hanauer S.B. Ulcerative colitis: Diagnosis and management. Hosp. Physician. 2002; 38(6): 53-63.
35. Kleessen B., Sykura B., Zunft H.J., Blaut M. Effects of inulin and lactose on faecal microflora, microbial activity and bowel habit in elderly constipated persons. Am. J. Clin. Nutr. 1997; 65: 1397-1402.
36. Kolida S. Tuohy K. Gibson G.R. Prebiotic effects of inulin and oligofructose. Br. J. Nutr. 2002; 87(2): S193-S197.
37. Kornbluth A., Sachar D.B. Ulcerative colitis practice guidelines in adults : American college of gastroenterology, practice parameters committee. Am. J. Gastroenterol. 2010; 105: 501-523.
38. Krishnamachari Y., Geary S.M., Lemke C.D., Salem A.K. Nanoparticle delivery systems in cancer vaccines. Pharm. Res. 2011; 28(2): 215-236.
39. Kruse H.P., Kleessen B., Blaut M. Effects of inulin on faecal bifidobacteria in human subjects. Br. J. Nutr.1999; 82: 375-382.
40. Kumar K.V.V., Sivakumar T., Mani T.T. Colon targeting drug delivery system: A review on recent approaches. Int. J. Pharm. Bio Sci. 2011; 2(1): 11-19.
41. Le Blay G., Michael C., Blottiere H.M., Cherbut C. Prolonged intake of fructo-oligosaccharides induces a short-term elevation of lactic acid producing bacteria and a persistent increase in cecal butyrate in rats. J. Nutr. 1999; 129: 2231-2235.
42. Le Leu R.K., Hu Y., Brown I.L., Woodman R.J., Young G.P. Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis. 2010; 31(2): 246-251.
43. Liong M.T. Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and in-vivo evidence. Int. J. Mol. Sci. 2008; 9: 854-863.
44. Louis P., Scott K.P., Duncan S.H., Flint H.J. Understanding the effects of diet on bacterial metabolism in the large intestine. J. Appl. Microbiol. 2007; 102: 1197-1208.
45. MacDermott R.P. Treatment of irritable bowel syndrome in outpatients with inflammatory bowel disease using a food and beverage intolerance, food and beverage avoidance diet. Inflamm. Bowel Dis. 2007; 13(1): 91-96.
46. Macgillivray P.C., Finlay H.V.L., Binns T.B. Use of lactulose to create a preponderance of Lactobacilli in the intestine of bottle fed infants. Scott. Med. J. 1959; 4: 182.
47. Mahadevan U., Sandborn W.J. Diagnosis and management of pouchitis. Gastroenterol. 2003; 124: 1636-1650.
48. Mao Y., Nobaek S., Kasravi B., Adawi D., Stenram U., Molin G., Jeppsson B. The effects of Lactobacillus strains and oat fiber onmethotrexate-induced enterocolitis in rats. Gastroenterol. 1996; 111(2): 334-344.
49. Minami Y., Yazawa K., Tamura Z., Tanaka T., Yamamoto T. Selectivity of utilization of galactosyl-oligosaccharides by bifidobacteria. Chem. Pharm. Bull (Tokyo) 1983; 31: 1688-1691.
50. Modan B., Cuckle H., Lubin F. A note on the role of dietary retinol and carotene in human gastrointestinal cancer. Int. J. Cancer 1981; 28: 421-424.
51. Novak J.S., Juneja V.K. Clostridium perfringens: hazards in new generation foods. Innov. Food Sci. Emerg. Technol. 2002; 3: 127-132.
52. Painter N.S. The high fibre diet in the treatment of diverticular disease of the colon. Postgrad. Med. J. 1974; 50: 629-635.
53. Phalipon A., Sansonetti P.J. Shigella's ways of manipulating the host intestinal innate and adaptive immune system: a tool box for survival?. Immunol. Cell Biol. 2007; 85: 119-129.
54. Philip A.K., Philip B. Colon targeted drug delivery systems: A review on primary and novel approaches. Oman Med. J. 2010; 25(2): 79- 87.
55. Rafter J. Lactic acid bacteria and cancer: mechanistic perspective. Br. J. Nutr. 2002; 88 (1): S89-S94.
56. Rafter J., Bennett M., Caderni G., Clune Y., Hughes R., Karlsson P.C., Klinder A., O'Riordan M., O'Sullivan G.C., Pool-Zobel B.L., Rechkemmer G., Roller M., Rowland I., Salvadori M., Thijs H., Loo J.V., Watzl B., Collins J.K. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 2007; 85: 488-496.
57. Roberfroid M.B. Prebiotics and synbiotics: concepts and nutritional properties. Br. J. Nutr., 1998; 80: S197-S202.
58. Roberfroid M. Prebiotics: the concept revisited. J Nutr. 2007;137: S830-S837.
59. Rowland I. Probiotics and colorectal cancer risk. Br. J. Nutr. 2004; 91: 805-807.
60. Rowland I.R., Rumney C.J., Coutts J.T., Lievense L.C. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis, 1998; 19(2): 281-285.
61. Roy M.K., Delicata R.J., Carey P.D. Crohn's disease presenting with acute colonic perforation. Postgrad. Med. J. 1997; 73: 645-666.
62. Sanders M.E. Probiotics. Food Technol. 1999; 53(11): 67-77.
63. Sauer J., Richter K.K., Pool-Zobel B.L. Products formed during fermentation of the prebiotic inulin with human gut flora enhance expression of biotransformation genes in human primary colon cells. Br. J. Nutr. 2007; 97(5): 928-937.
64. Schrezenmeir J., Vrese M.D. Probiotics, prebiotics, and synbiotics-approaching a definition. Am. J Clin. Nutr. 2001; 73: S361- S364.
65. Sekhon B.S., Jairath S. Prebiotics, probiotics and synbiotics: an overview. J Pharm. Educ. Res. 2010; 1(2): 13-36.
66. Sghir A., Chow J.M., Mackie R.I. Continuous culture selection of bifidobacteria and lactobacilli from human faecal samples using fructooligosaccharide as selective substrate. J. Appl. Microbiol. 1998; 85: 769-777.
67. Stollman N.H., Raskin J.B. Diagnosis and management of diverticular disease of the colon in adults. Am. J. Gastroenterol. 1999; 94(11): 3110-3121.
68. Strojný L., Bomba A., Hijovà E., Chmelàrovà A., Mojžišovà G., Bertkovà I., Koprovicovà J., Pomfy M., Strompfovà V., Molokàcovà M. Efects of a probiotic in combination with prebiotic on intestinal lactobacilli and coliforms and activity of bacterial enzymes in 1,2- dimethylhydrazine exposed rats. Czech. J. Anim. Sci. 2011; 56 (3): 99- 106.
69. Suvarna V.C., Boby V.U. Probiotics in human health: A current assessment. Curr. Sci. 2005; 88(11): 1744-1748.
70. Swennen K., Courtin C.M., Delcour J.A. Non-digestible oligosaccharides with prebiotic properties. Crit. Rev. Food Sci. Nutr. 2006; 46: 459-471.
71. Tamura K., Ishiguro S., Munakata A. ,Yoshida Y., Nakaji S., Suguwara K. Annual changes in colorectal carcinoma incidence in Japan: Analysis of survey data on incidence in aomori prefecture. Cancer. 1996; 78: 1187-1194.
72. Tannock G.W. (1994). More than a smell: The complexity of the normal microflora. In G.W. Tannock (Ed.) Normal Microflora. An Introduction to Microbes Inhabiting the Human Body (pp. 1-36). London : Chapman and Hall publishers.
73. Tannock G.W. The microecology of lactobacilli inhabiting the gastrointestinal tract. Adv. Microb. Ecol. 1990; 11: 147-171.
74. Tannock G.W. (1983). Effect of dietary and environmental stress on the gastrointestinal microbiota. In D.J. Hentges (Ed.) Human Intestinal Microflora in Health and Disease (pp. 517-539), London: Academic Press, Inc.
75. Thun M.J., Calle E.E., Namboodiri M.M., Flanders W.D., Coates R.J., Byers T., et al. Risk factors for fatal colon cancer in a large prospective study. J. Nat. Cancer Inst. 1992; 84: 1491-1500.
76. Tuohy K.M., Kolida S., Lustenberger A. Gibson G.R. The prebiotic effects of biscuits containing partially hydrolyzed guar gum and fructooligosaccharides - A human volunteer study. Br. J. Nutr. 2001; 86: 341-348.
77. Tuohy K.M., Rouzaud G.C., Brück W.M., Gibson G.R. Modulation of the human gut microflora towards improved health using prebiotics - Assessment of efficacy. Curr. Pharm. Des. 2005; 11: 75-90.
78. Verghese M., Rao D.R., Chawan C.B., Shackelford L. Dietary inulin suppresses azoxymethane-induced preneoplastic aberrant crypt foci in mature fisher 344 rats. J. Nutr. 2002; 132: 2804-2808.
79. Videla S. Deranged luminal pH homeostasis in experimental colitis can be restored by a prebiotic. Gastroenterol. 1999; 116: A942.
80. Videla S., Vilaseca J., Garcia-Lafuente A., Antolin M., Crespo E., Guarner F. Malagelada J.R. Dietary inulin prevents distal colitis induced by dextran sulfate sodium (DSS). Gastroenterol. 1998; 114: A1110.
81. Vollaard E.J., Clasener H.A.L. Colonization resistance. Antimicrob. Agents Chemother. 1994; 38: 409-414.
82. Wang X., Gibson G.R. Effects of the in vivo fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J. Appl. Bacteriol. 1993; 75: 373-380.
83. Willett W.C., Stampfer M.J., Colditz G.A., Rosner B.A., Speizer F.E. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N. Engl. J. Med.1990; 323: 1664-1672.
84. Williams C.H., Witherly S.A., Buddington R.K. Influence of dietary Neosugar on selected bacteria groups of the human fecal microbiota. Microb. Ecol. Health Dis.1994; 7: 91-97.
85. Wollowski I., Rechkemmer G., Pool-Zobel B.L. Protective role of probiotics and prebiotics in colon cancer. Am. J. Clin. Nutr. 2001; 73: S451-S455.
86. Yazawa K., Imai K., Tamura Z. Oligosaccharides and polysaccharides specifically utilizable by bifidobacteria. Chem. Pharm. Bull (Tokyo) 1978; 26: 3306-3311.
87. Younes H., Coudray C., Bellanger J., Demigné C., Rayssiguier Y., Rémésy C. Effects of two fermentable carbohydrates (inulin and resistant starch) and their combination on calcium and magnesium balance in rats. Br. J. Nutr.2001; 86(4): 479-485.
88. Young G.P. Colorectal disorders: A dietary management perspective. Asia Pac. J. Clin. Nutr. 2000; 9: S76-S82.